$ Value
$26K
Shares
1,336
Price
$20
Filed
Mar 3
Insider
Name
Rosenbloom David S.
Title
EVP and General Counsel
CIK
0001924321
Roles
Transaction Details
Transaction Date
2026-03-02
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
144,837
Footnotes
The reporting person received a grant of restricted stock units which are scheduled to vest in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date, subject to satisfaction of the related vesting requirements set forth in the Amended and Restated Baxter International Inc. 2021 Incentive Plan. | Represents the number of shares forfeited by the reporting person to cover the withholding of taxes incurred as a result of the delivery of shares on March 2, 2026 from the settlement of vested restricted stock units granted on March 1, 2023. | The options become exercisable in three equal annual installments beginning on March 1, 2027, the first anniversary of the grant date.
Filing Info
Rosenbloom David S.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-06 | BAX | F | $117K |
| 2026-03-02 | BAX | F | $26K |
| 2026-02-27 | BAX | A | $0 |
| 2026-02-27 | BAX | A | $0 |
| 2026-02-09 | BAX | A | $0 |
| 2026-02-09 | BAX | F | $114K |
| 2025-06-02 | BAX | F | $489K |
Other Insiders at BAX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| McDonnell Michael R. | — | — | 2026-02-13 |
|
Grade Joel T.
EVP and CFO
|
— | — | 2026-03-06 |
|
Zielinski Anita A
SVP, CAO and Controller
|
— | — | 2026-03-06 |
|
Rosenbloom David S.
EVP and General Counsel
|
— | — | 2026-03-06 |
|
Hider Andrew P.
President and CEO
|
— | — | 2026-02-27 |
|
Rasul Reazur
EVP,Group Pres,Healthcare
|
— | — | 2026-03-06 |
|
Carlisle Cynthia
Executive Vice President, CHRO
|
— | — | 2026-02-27 |
|
Soriano Maria Cecilia
Group Pres., ITT & Pharma.
|
— | — | 2026-03-06 |